AQR Capital Management Portfolio holdings
AUM
$121B
1-Year Return
23.38%
This Quarter Return
-12.77%
1 Year Return
+23.38%
3 Year Return
+85.44%
5 Year Return
+156.19%
10 Year Return
+370.97%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$649M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,361
New
151
Increased
1,005
Reduced
997
Closed
188
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CVS Health
CVS
|
+$185M |
| 3 |
Tyson Foods
TSN
|
+$130M |
| 4 |
Exxon Mobil
XOM
|
+$128M |
| 5 |
Citigroup
C
|
+$110M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$232M |
| 2 |
Microsoft
MSFT
|
+$191M |
| 3 |
Johnson & Johnson
JNJ
|
+$156M |
| 4 |
Allstate
ALL
|
+$128M |
| 5 |
Walmart
WMT
|
+$120M |
Sector Composition
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.38% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Heritage Commerce
HTBK
$630M
| $194K | ﹤0.01% |
18,157
+2,013
| +12% | +$21.5K |
|
2002
Concrete Pumping Holdings
BBCP
$366M
| $189K | ﹤0.01% |
31,269
-4,370
| -12% | -$26.4K |
|
2003
Crinetics Pharmaceuticals
CRNX
$3.3B
| $189K | ﹤0.01% |
10,138
-16,268
| -62% | -$303K |
|
2004
Ardmore Shipping
ASC
$502M
| $188K | ﹤0.01% |
+26,945
| New | +$188K |
|
|
GMRE
2005
Global Medical REIT
GMRE
$511M
| $187K | ﹤0.01% |
+16,673
| New | +$187K |
|
2006
Dynavax Technologies
DVAX
$1.14B
| $185K | ﹤0.01% |
14,695
-5,844
| -28% | -$73.6K |
|
2007
Uranium Energy
UEC
$5.6B
| $185K | ﹤0.01% |
60,129
+13
| +0% | +$40 |
|
|
XHR
2008
Xenia Hotels & Resorts
XHR
$1.38B
| $181K | ﹤0.01% |
12,489
+1,553
| +14% | +$22.5K |
|
2009
Adtran
ADTN
$828M
| $179K | ﹤0.01% |
10,231
-39
| -0.4% | -$682 |
|
|
PSTL
2010
Postal Realty Trust
PSTL
$392M
| $177K | ﹤0.01% |
11,864
+1,196
| +11% | +$17.8K |
|
2011
Energy Fuels
UUUU
$2.91B
| $175K | ﹤0.01% |
35,725
| – | – |
|
2012
Vertex
VERX
$3.81B
| $172K | ﹤0.01% |
+15,200
| New | +$172K |
|
2013
Kodiak Sciences
KOD
$513M
| $170K | ﹤0.01% |
22,220
-16,191
| -42% | -$124K |
|
|
ACCD
2014
DELISTED
Accolade, Inc. Common Stock
ACCD
| $169K | ﹤0.01% |
+22,852
| New | +$169K |
|
2015
MBIA
MBI
$374M
| $166K | ﹤0.01% |
+13,474
| New | +$166K |
|
|
AIV
2016
Aimco
AIV
$1.07B
| $165K | ﹤0.01% |
26,991
+1,359
| +5% | +$8.31K |
|
2017
Carisma Therapeutics
CARM
$16.4M
| $164K | ﹤0.01% |
10,096
+8,431
| +506% | +$137K |
|
2018
Aldeyra Therapeutics
ALDX
$333M
| $163K | ﹤0.01% |
+40,954
| New | +$163K |
|
2019
OraSure Technologies
OSUR
$238M
| $163K | ﹤0.01% |
+60,209
| New | +$163K |
|
2020
Veritone
VERI
$201M
| $163K | ﹤0.01% |
+24,975
| New | +$163K |
|
2021
Riot Platforms
RIOT
$6.06B
| $162K | ﹤0.01% |
+38,730
| New | +$162K |
|
|
TVRD
2022
Tvardi Therapeutics, Inc. Common Stock
TVRD
$308M
| $160K | ﹤0.01% |
485
-708
| -59% | -$234K |
|
2023
Blue Owl Capital
OWL
$12.1B
| $159K | ﹤0.01% |
+15,895
| New | +$159K |
|
2024
Globalstar
GSAT
$3.94B
| $158K | ﹤0.01% |
8,571
+2,343
| +38% | +$43.2K |
|
2025
AquaBounty Technologies
AQB
$4.46M
| $157K | ﹤0.01% |
4,581
+2,195
| +92% | +$75.2K |
|